Patents for A61P 35 - Antineoplastic agents (221,099)
12/2012
12/19/2012CN102824383A Method for extracting madagascar periwinkle herb total alkaloid
12/19/2012CN102824381A Isatis root and vitamin C tablet and preparation method thereof
12/19/2012CN102824380A Application of Lianzhi anti-inflammation dropping pills in preparing medicine for suppressing HT1080 cell proliferation
12/19/2012CN102824376A Cordyceps sinensis powder and preparation method and application thereof
12/19/2012CN102824375A Application of Wuling capsule in preparation of medicament for inhibiting proliferation of U251 cell
12/19/2012CN102824352A Application of disaccharide compound in preparing anti-tumor medicine
12/19/2012CN102824351A Application of disaccharide compound in preparation of antiviral drug
12/19/2012CN102824348A New technology for extracting sterol from corn germ oil deodorization distillate
12/19/2012CN102824347A Application of securinine in preparing medicine for suppressing MDA-MB-157 cell proliferation
12/19/2012CN102824346A Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin
12/19/2012CN102824345A Irinotecan hydrochloride composition and preparation method thereof
12/19/2012CN102824344A Pharmaceutical composition utilizing berberine to inhibit cancer stem cell growth or cancer cell metastasis, and application thereof
12/19/2012CN102824334A Anti-cancer drug
12/19/2012CN102824325A Quercetin sustained release tablet and preparing method thereof
12/19/2012CN102824320A Phytosterol tablet and preparation method thereof
12/19/2012CN102824306A Folic acid modified chitosan coated plasmid nanoparticles and preparation method thereof
12/19/2012CN102823792A Soft propolis astragalus mongholicus capsule and preparation method thereof
12/19/2012CN102379860B Biological illuminated drug carrier and preparation method thereof
12/19/2012CN102293765B Application of isoflavone compound to preparation of antitumor medicines or food
12/19/2012CN102286324B Method for preparing gingko golden fungus fruit wine
12/19/2012CN102268099B Rangoon creeper fruit extract and extraction method thereof
12/19/2012CN102180985B Method for extracting and purifying mugwort polysaccharides
12/19/2012CN102154206B Preparation method of high-purity, high-multiplication capacity and high-cytotoxin activity CIK (cytokine induced kill) cell
12/19/2012CN102038959B Application of let-7/miR-98 family in preparation of medicament for treating disease related to FAS (Fatty Acid Synthase) gene
12/19/2012CN102008475B Application of quinolizidine in preparing tumor treatment drugs
12/19/2012CN101974535B Preparation and application of novel anti-ErbB2 humanized antibody MIL12
12/19/2012CN101780150B Plant extract and pharmaceutical composition for treating cough and preparation method thereof
12/19/2012CN101732720B Preparation and application of anti-cancer medicament carrier with dual functions of targeting and fluorescence
12/19/2012CN101596159B New taxol injection and preparation method thereof
12/19/2012CN101574375B Lactobacillus health-care capsule and preparation method thereof
12/19/2012CN101538258B Compound of salvia miltiorrhiza and derivative, preparation method and medicine application thereof
12/19/2012CN101495148B Pharmaceutical composition comprising at least one anticancer drug and at least one polymer
12/19/2012CN101337992B Fusion protein of urokinase type plasminogen activator a chain and melittin and preparation thereof
12/19/2012CN101115728B Triazole substituted aminobenzophenone compounds
12/18/2012US8334370 Polynucleotides comprising intercalating entities
12/18/2012US8334313 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
12/18/2012US8334260 sFRP and peptide motifs that interact with sFRP and methods of their use
12/18/2012US8333961 Natural liniment for treatment of skin cancers
12/18/2012US8333958 HSA-free formulations of interferon-Beta
12/18/2012US8333953 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/18/2012CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis
12/18/2012CA2720944C Compounds and compositions as kinase inhibitors
12/18/2012CA2589421C Erbb3 antibodies
12/18/2012CA2514552C Adjuvant used in dielectric heating-assisted cancer treatment, and cancer treatment method
12/18/2012CA2504665C Combination of a nitrogen mustard analogue and imatinib for the treatment of chronic lymphocytic leukemia
12/18/2012CA2472163C Psoriasin expression by breast epithelial cells
12/18/2012CA2398064C 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
12/18/2012CA2345109C Receptor based antagonists and methods of making and using
12/13/2012WO2012171024A2 Enzyme directed assembly of particle theranostics
12/13/2012WO2012171020A1 Protein-polymer-drug conjugates
12/13/2012WO2012171007A2 Methods for treating or preventing graft versus host disease
12/13/2012WO2012171002A1 Synthesis and characterization of second generation benzofuranone ring substituted noscapine analogs
12/13/2012WO2012170976A2 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
12/13/2012WO2012170929A2 Monoclonal antibody and antigens for diagnosing and treating lung disease and injury
12/13/2012WO2012170785A1 Anti-cd22 antigen binding molecules to treat lung cancer and prostate cancer
12/13/2012WO2012170776A2 Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy
12/13/2012WO2012170742A2 Treatment and prevention of cancer with hmgb1 antagonists
12/13/2012WO2012170720A2 Methods and compositions for treating brain cancer
12/13/2012WO2012170664A2 Methods of cancer treatment and prevention through the modulation of sirt4 activity
12/13/2012WO2012170573A2 New taccalonolide microtubule stabilizers
12/13/2012WO2012170513A2 He4 based therapy for malignant disease
12/13/2012WO2012170384A1 Use of metallocene compounds for cancer treatment
12/13/2012WO2012170084A1 Composition and method for treating lung disease and mucous cell metaplasia
12/13/2012WO2012170072A1 Engineered antibody-tnfsf member ligand fusion molecules
12/13/2012WO2012169973A1 A core-shell nanoparticle
12/13/2012WO2012169934A1 Novel kinase inhibitors
12/13/2012WO2012169822A2 Fusion protein for suppressing cancer cell growth and suppressing vasculogenesis, and anticancer composition comprising same
12/13/2012WO2012169785A2 Symmetrically structured quinazoline derivatives
12/13/2012WO2012169733A1 Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant
12/13/2012WO2012169200A1 Sema5b peptides and vaccines including the same
12/13/2012WO2012168908A1 Peptides for use in cancer treatment
12/13/2012WO2012168885A2 Bisacodyl and analogues as drugs for treating cancer
12/13/2012WO2012168884A1 Heterocyclic sulfonamide derivatives
12/13/2012WO2012168721A1 Materials and methods for treating pten mutated or deficient cancer
12/13/2012WO2012168720A1 MATERIALS AND METHODS FOR TREATING ESTROGEN RECEPTOR α (ER) POSITIVE CANCER
12/13/2012WO2012168464A1 Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof
12/13/2012WO2012168462A1 Antiinfective composition
12/13/2012WO2012168401A1 Use of photolyase for reducing or improving subclinical field cancerization associated with actinic keratosis
12/13/2012WO2012168259A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and triple-negative breast cancer
12/13/2012WO2012167944A1 Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy
12/13/2012WO2012167869A1 Amino lipids, their synthesis and uses thereof
12/13/2012WO2012167733A1 Substituted pyridopyrazines as novel syk inhibitors
12/13/2012WO2012167656A1 Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof
12/13/2012WO2012167606A1 Pyridonaphthyridine pi3k/mtor dual inhibitors and preparation and use thereof
12/13/2012WO2012167600A1 A heterocyclic [b]pyridone compound, intermediates thereof, method of preparation and uses
12/13/2012WO2012167434A1 A pharmaceutical composition for inhibiting recurrence, aggravation and metastasis of hepatocarcinoma
12/13/2012WO2012167415A1 Pyrimidopyrimidone derivatives, pharmaceutical compositions and uses thereof
12/13/2012WO2012167382A1 Compositions and methods for glioblastoma treatment
12/13/2012WO2012167368A1 Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism
12/13/2012WO2012167364A1 Phenolic compounds with antioxidant and anti-cancer properties, analogs and synthesis thereof
12/13/2012WO2012151525A9 Novel compounds as modulators of protein kinases
12/13/2012WO2012143499A3 Novel binder-drug conjugates (adcs) and their use
12/13/2012WO2012143495A3 Novel binder-drug conjugates (adcs) and their use
12/13/2012WO2012135637A3 Inhibition of macrophage-synthesized wnt7b to inhibit tumor angiogenesis and metastasis
12/13/2012WO2012131717A3 2',3'-epoxypropyl-3.4-dihydroxy benzene and a process for the preparation thereof
12/13/2012WO2012126118A8 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
12/13/2012WO2012119010A3 Materials for inhibiting aromatase and method of using the same to diagnose, treat and monitor breast cancer
12/13/2012WO2012118353A3 Pharmaceutical composition containing an endocytic motif and protein transduction domains for preventing or treating cancer
12/13/2012WO2012094653A3 Compositions and methods for macromolecular drug delivery
12/13/2012WO2012015677A9 6-(1-methyl-1h-pyrazol-4-yl)-3-(2-methyl-2h-indazol-5-ylthio)-[1,2,4] triazolo [4,3-b] pyridazine as a c-met inhibitor